Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19125 entries
Sorted by: Best Match Show Resources per page
Cryptic Loss of Consciousness in a 36-Year-Old Woman.

Stroke

Martinez Majander N, Sinisalo J, Sundararajan S, Strbian D, Putaala J.
PMID: 25967578
Stroke. 2015 Jul;46(7):e164-6. doi: 10.1161/STROKEAHA.115.009405. Epub 2015 May 12.

No abstract available.

Cite
Martinez Majander N, Sinisalo J, Sundararajan S, et al. Cryptic Loss of Consciousness in a 36-Year-Old Woman. Stroke. 2015;46(7):e164-6doi: 10.1161/STROKEAHA.115.009405.
Martinez Majander, N., Sinisalo, J., Sundararajan, S., Strbian, D., & Putaala, J. (2015). Cryptic Loss of Consciousness in a 36-Year-Old Woman. Stroke, 46(7), e164-6. https://doi.org/10.1161/STROKEAHA.115.009405
Martinez Majander, Nicolas, et al. "Cryptic Loss of Consciousness in a 36-Year-Old Woman." Stroke vol. 46,7 (2015): e164-6. doi: https://doi.org/10.1161/STROKEAHA.115.009405
Martinez Majander N, Sinisalo J, Sundararajan S, Strbian D, Putaala J. Cryptic Loss of Consciousness in a 36-Year-Old Woman. Stroke. 2015 Jul;46(7):e164-6. doi: 10.1161/STROKEAHA.115.009405. Epub 2015 May 12. PMID: 25967578.
Copy Download .nbib Format: NLM
Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?.

Thrombosis research

Skeith L, Le Gal G, Rodger MA.
PMID: 33836493
Thromb Res. 2021 Jun;202:134-138. doi: 10.1016/j.thromres.2021.03.012. Epub 2021 Mar 25.

Exogenous hormone therapies, such as combined oral contraceptives (COC) and hormone replacement therapy (HRT), cause blood hypercoagulability and are a risk factor for venous thromboembolism (VTE). There is controversy on how strong this "provoking" risk factor is, and how...

Cite
Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?. Thromb Res. 2021;202:134-138doi: 10.1016/j.thromres.2021.03.012.
Skeith, L., Le Gal, G., & Rodger, M. A. (2021). Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?. Thrombosis research, 202134-138. https://doi.org/10.1016/j.thromres.2021.03.012
Skeith, Leslie, et al. "Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?." Thrombosis research vol. 202 (2021): 134-138. doi: https://doi.org/10.1016/j.thromres.2021.03.012
Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?. Thromb Res. 2021 Jun;202:134-138. doi: 10.1016/j.thromres.2021.03.012. Epub 2021 Mar 25. PMID: 33836493.
Copy Download .nbib Format: NLM
Premenstrual dysphoric disorder: burden of illness and treatment update.

Journal of psychiatry & neuroscience : JPN

Pearlstein T, Steiner M.
PMID: 18592027
J Psychiatry Neurosci. 2008 Jul;33(4):291-301.

Five percent of menstruating women have severe premenstrual symptoms and impairment of functioning defined as premenstrual dysphoric disorder (PMDD). Clinically significant premenstrual symptoms occur in at least an additional 20% of menstruating women. The diagnosis of PMDD should be...

Cite
Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci. 2008;33(4):291-301
Pearlstein, T., & Steiner, M. (2008). Premenstrual dysphoric disorder: burden of illness and treatment update. Journal of psychiatry & neuroscience : JPN, 33(4), 291-301.
Pearlstein, Teri, and Steiner, Meir. "Premenstrual dysphoric disorder: burden of illness and treatment update." Journal of psychiatry & neuroscience : JPN vol. 33,4 (2008): 291-301.
Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci. 2008 Jul;33(4):291-301. PMID: 18592027; PMCID: PMC2440788.
Copy Download .nbib Format: NLM
An Update on Contraception in Polycystic Ovary Syndrome.

Endocrinology and metabolism (Seoul, Korea)

Oguz SH, Yildiz BO.
PMID: 33853290
Endocrinol Metab (Seoul). 2021 Apr;36(2):296-311. doi: 10.3803/EnM.2021.958. Epub 2021 Apr 15.

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology. Combined oral contraceptives (COCs), along with lifestyle modifications, represent the first-line medical treatment for the long-term management of PCOS....

Cite
Oguz SH, Yildiz BO. An Update on Contraception in Polycystic Ovary Syndrome. Endocrinol Metab (Seoul). 2021;36(2):296-311doi: 10.3803/EnM.2021.958.
Oguz, S. H., & Yildiz, B. O. (2021). An Update on Contraception in Polycystic Ovary Syndrome. Endocrinology and metabolism (Seoul, Korea), 36(2), 296-311. https://doi.org/10.3803/EnM.2021.958
Oguz, Seda Hanife, and Yildiz, Bulent Okan. "An Update on Contraception in Polycystic Ovary Syndrome." Endocrinology and metabolism (Seoul, Korea) vol. 36,2 (2021): 296-311. doi: https://doi.org/10.3803/EnM.2021.958
Oguz SH, Yildiz BO. An Update on Contraception in Polycystic Ovary Syndrome. Endocrinol Metab (Seoul). 2021 Apr;36(2):296-311. doi: 10.3803/EnM.2021.958. Epub 2021 Apr 15. PMID: 33853290; PMCID: PMC8090477.
Copy Download .nbib Format: NLM
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake.

BMJ sexual & reproductive health

Begg L, Brodsky R, Friedland B, Mathur S, Sailer J, Creasy G.
PMID: 32737137
BMJ Sex Reprod Health. 2021 Jul;47(3):166-172. doi: 10.1136/bmjsrh-2020-200662. Epub 2020 Jul 31.

INTRODUCTION: Uptake of oral pre-exposure prophylaxis (PrEP) remains low. The objective of this analysis was to estimate the potential market size in priority sub-Saharan African countries for a 28-day dual prevention pill (DPP) regimen containing the active pharmaceutical ingredients...

Cite
Begg L, Brodsky R, Friedland B, et al. Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake. BMJ Sex Reprod Health. 2020;47(3):166-172doi: 10.1136/bmjsrh-2020-200662.
Begg, L., Brodsky, R., Friedland, B., Mathur, S., Sailer, J., & Creasy, G. (2021). Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake. BMJ sexual & reproductive health, 47(3), 166-172. https://doi.org/10.1136/bmjsrh-2020-200662
Begg, Lorna, et al. "Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake." BMJ sexual & reproductive health vol. 47,3 (2021): 166-172. doi: https://doi.org/10.1136/bmjsrh-2020-200662
Begg L, Brodsky R, Friedland B, Mathur S, Sailer J, Creasy G. Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake. BMJ Sex Reprod Health. 2021 Jul;47(3):166-172. doi: 10.1136/bmjsrh-2020-200662. Epub 2020 Jul 31. PMID: 32737137; PMCID: PMC8292580.
Copy Download .nbib Format: NLM
The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases.

Intestinal research

Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW.
PMID: 30090040
Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27.

BACKGROUND/AIMS: To examine the association between use of oral contraceptive pills (OCPs) and the risk of developing inflammatory bowel diseases (IBD), in a modern cohort.METHODS: A prospective nested case-control study across sites in the Asia-Pacific region was conducted; involving...

Cite
Sanagapalli S, Ko Y, Kariyawasam V, et al. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res. 2018;16(3):409-415doi: 10.5217/ir.2018.16.3.409.
Sanagapalli, S., Ko, Y., Kariyawasam, V., Ng, S. C., Tang, W., de Silva, H. J., Chen, M., Wu, K., Aniwan, S., Ng, K. K., Ong, D., Ouyang, Q., Hilmi, I., Simadibrata, M., Pisespongsa, P., Gopikrishna, S., Leong, R. W. (2018). The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intestinal research, 16(3), 409-415. https://doi.org/10.5217/ir.2018.16.3.409
Sanagapalli, Santosh, et al. "The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases." Intestinal research vol. 16,3 (2018): 409-415. doi: https://doi.org/10.5217/ir.2018.16.3.409
Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27. PMID: 30090040; PMCID: PMC6077300.
Copy Download .nbib Format: NLM
[Risk of alveolitis after dental extraction].

Stomatologie der DDR

Klammt J, Gänsicke A, Gänsicke W, Kunkel J, Müller U, Pingel G, Scheibner B, Scheibner F, Schubert F.
PMID: 3868844
Stomatol DDR. 1985 Oct;35(10):586-93.

No abstract available.

Cite
Klammt J, Gänsicke A, Gänsicke W, et al. Das Risiko der Alveolitis nach Zahnextraktion. [Risk of alveolitis after dental extraction]. Stomatol DDR. 1985;35(10):586-93
Klammt, J., Gänsicke, A., Gänsicke, W., Kunkel, J., Müller, U., Pingel, G., Scheibner, B., Scheibner, F., & Schubert, F. (1985). Das Risiko der Alveolitis nach Zahnextraktion. [Risk of alveolitis after dental extraction]. Stomatologie der DDR, 35(10), 586-93.
Klammt, J, et al. "Das Risiko der Alveolitis nach Zahnextraktion." [Risk of alveolitis after dental extraction]. Stomatologie der DDR vol. 35,10 (1985): 586-93.
Klammt J, Gänsicke A, Gänsicke W, Kunkel J, Müller U, Pingel G, Scheibner B, Scheibner F, Schubert F. Das Risiko der Alveolitis nach Zahnextraktion. [Risk of alveolitis after dental extraction]. Stomatol DDR. 1985 Oct;35(10):586-93. German. PMID: 3868844.
Copy Download .nbib Format: NLM
Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro.

Biochemical pharmacology

Weinstein I, Belitsky R, Seedman S, Friegly MJ, Trasher TN.
PMID: 1191317
Biochem Pharmacol. 1975 Sep 01;24(17):1583-8. doi: 10.1016/0006-2952(75)90083-0.

No abstract available.

Cite
Weinstein I, Belitsky R, Seedman S, et al. Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro. Biochem Pharmacol. 1975;24(17):1583-8doi: 10.1016/0006-2952(75)90083-0.
Weinstein, I., Belitsky, R., Seedman, S., Friegly, M. J., & Trasher, T. N. (1975). Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro. Biochemical pharmacology, 24(17), 1583-8. https://doi.org/10.1016/0006-2952(75)90083-0
Weinstein, I, et al. "Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro." Biochemical pharmacology vol. 24,17 (1975): 1583-8. doi: https://doi.org/10.1016/0006-2952(75)90083-0
Weinstein I, Belitsky R, Seedman S, Friegly MJ, Trasher TN. Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro. Biochem Pharmacol. 1975 Sep 01;24(17):1583-8. doi: 10.1016/0006-2952(75)90083-0. PMID: 1191317.
Copy Download .nbib Format: NLM
[Practical postgraduate course in diabetology (author's transl)].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis

Berger W.
PMID: 1161741
Schweiz Rundsch Med Prax. 1975 May 20;64(20):626-31.

No abstract available.

Cite
Berger W. Praktische Fortibildung in Diabetologie [Practical postgraduate course in diabetology (author's transl)]. Schweiz Rundsch Med Prax. 1975;64(20):626-31
Berger, W. (1975). Praktische Fortibildung in Diabetologie [Practical postgraduate course in diabetology (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 64(20), 626-31.
Berger, W. "Praktische Fortibildung in Diabetologie" [Practical postgraduate course in diabetology (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis vol. 64,20 (1975): 626-31.
Berger W. Praktische Fortibildung in Diabetologie [Practical postgraduate course in diabetology (author's transl)]. Schweiz Rundsch Med Prax. 1975 May 20;64(20):626-31. German. PMID: 1161741.
Copy Download .nbib Format: NLM
Drug-induced deafness and its treatment.

The Practitioner

Ajodhia JM, Dix MR.
PMID: 951390
Practitioner. 1976 May;216(1295):561-70.

A comprehensive review is presented of the ototoxic effects of drugs which may damage hearing. These have been classified in tabular form together with the recommended dose, method of administration, and ill-effects upon the inner ear. Special emphasis is...

Cite
Ajodhia JM, Dix MR. Drug-induced deafness and its treatment. Practitioner. 1976;216(1295):561-70
Ajodhia, J. M., & Dix, M. R. (1976). Drug-induced deafness and its treatment. The Practitioner, 216(1295), 561-70.
Ajodhia, J M, and Dix, M R. "Drug-induced deafness and its treatment." The Practitioner vol. 216,1295 (1976): 561-70.
Ajodhia JM, Dix MR. Drug-induced deafness and its treatment. Practitioner. 1976 May;216(1295):561-70. PMID: 951390.
Copy Download .nbib Format: NLM
Letter: Contraceptive practice and unplanned pregnancy in students.

British medical journal

King L.
PMID: 1192155
Br Med J. 1975 Nov 29;4(5995):519-20. doi: 10.1136/bmj.4.5995.519-d.
Free PMC Article

No abstract available.

Cite
King L. Letter: Contraceptive practice and unplanned pregnancy in students. Br Med J. 1975;4(5995):519-20doi: 10.1136/bmj.4.5995.519-d.
King, L. (1975). Letter: Contraceptive practice and unplanned pregnancy in students. British medical journal, 4(5995), 519-20. https://doi.org/10.1136/bmj.4.5995.519-d
King, L. "Letter: Contraceptive practice and unplanned pregnancy in students." British medical journal vol. 4,5995 (1975): 519-20. doi: https://doi.org/10.1136/bmj.4.5995.519-d
King L. Letter: Contraceptive practice and unplanned pregnancy in students. Br Med J. 1975 Nov 29;4(5995):519-20. doi: 10.1136/bmj.4.5995.519-d. PMID: 1192155; PMCID: PMC1675604.
Copy Download .nbib Format: NLM
[Peculiar changes of the epithelium and regressive processes in the endometrium of the body of the uterus].

Verhandlungen der Deutschen Gesellschaft fur Pathologie

Schmid KO.
PMID: 4182257
Verh Dtsch Ges Pathol. 1968;52:349-56.

No abstract available.

Cite
Schmid KO. Uber eigenartige Epithelveränderungen und Rückbildungsvorgänge im Corpusendometrium. [Peculiar changes of the epithelium and regressive processes in the endometrium of the body of the uterus]. Verh Dtsch Ges Pathol. 1968;52:349-56
Schmid, K. O. (1968). Uber eigenartige Epithelveränderungen und Rückbildungsvorgänge im Corpusendometrium. [Peculiar changes of the epithelium and regressive processes in the endometrium of the body of the uterus]. Verhandlungen der Deutschen Gesellschaft fur Pathologie, 52349-56.
Schmid, K O. "Uber eigenartige Epithelveränderungen und Rückbildungsvorgänge im Corpusendometrium." [Peculiar changes of the epithelium and regressive processes in the endometrium of the body of the uterus]. Verhandlungen der Deutschen Gesellschaft fur Pathologie vol. 52 (1968): 349-56.
Schmid KO. Uber eigenartige Epithelveränderungen und Rückbildungsvorgänge im Corpusendometrium. [Peculiar changes of the epithelium and regressive processes in the endometrium of the body of the uterus]. Verh Dtsch Ges Pathol. 1968;52:349-56. German. PMID: 4182257.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19125 entries